These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 614148)

  • 1. [Bacteriocins as cytotoxic agents in experimental neoplasms: considerations on the role of possible contaminants].
    Fumarola D; Bello P; Palma R; Miragliotta G; Panaro A
    G Batteriol Virol Immunol; 1977; 70(1-6):87-93. PubMed ID: 614148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.
    Farkas-Himsley H; Cheung R
    Cancer Res; 1976 Oct; 36(10):3561-7. PubMed ID: 953984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocins as cytotoxic agents against tumors: the role of possible contaminants.
    Fumarola D
    Boll Ist Sieroter Milan; 1978 Mar; 57(1):101-2. PubMed ID: 656190
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possible contamination of preparation of transfer factor with bacterial endotoxins].
    Fumarola D; Panaro A; Longo-Papadia L; Papadia J
    G Batteriol Virol Immunol; 1976; 69(7-12):229-33. PubMed ID: 1028644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of pyocin P1 on Salmonella minnesota Rd1 (proceedings)].
    Krämer J; Israil I; Brandis H
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):338-41. PubMed ID: 983521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possible use of pyocins against Pseudomonas aeruginosa (author's transl)].
    Sezen IY; Blobel H; Scharmann W
    Zentralbl Bakteriol Orig A; 1974; 229(2):205-8. PubMed ID: 4155865
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relations between antibiotic resistance and pyocin P3 resistance in Pseudomonas aeruginosa mutants].
    García-Quintana HG; Wilckens R
    Zentralbl Veterinarmed B; 1983 Apr; 30(3):169-74. PubMed ID: 6408850
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the host range specificity of pyocin P1.
    Brandis H; Krämer J; Israil A
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):13-20. PubMed ID: 813612
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of possible endotoxin contaminants present in some preparations of biological products and injectable drugs].
    Fumarola D
    Ann Sclavo; 1978; 20(4):546-57. PubMed ID: 380476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of trewiasine in 4 human cancer cell lines and 5 murine tumors.
    Yue XF; Han JX; Shen ZM; Yang WY; Lu LJ; Li BJ; Wang C; Xu XK
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):252-5. PubMed ID: 1442109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified colicin as cytotoxic agent of neoplasia: comparative study with crude colicin.
    Farkas-Himsley H; Yu H
    Cytobios; 1985; 42(167-168):193-207. PubMed ID: 3891240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic properties of bacteriocins: revisiting potential active agents.
    Cornut G; Fortin C; Soulières D
    Am J Clin Oncol; 2008 Aug; 31(4):399-404. PubMed ID: 18846002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies of the action of a partially purified bacteriocin against a murine fibrosarcoma.
    Hill RP; Farkas-Himsley H
    Cancer Res; 1991 Mar; 51(5):1359-65. PubMed ID: 1997173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines.
    Abdi-Ali A; Worobec EA; Deezagi A; Malekzadeh F
    Can J Microbiol; 2004 May; 50(5):375-81. PubMed ID: 15213746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriocin-based strategies for food biopreservation.
    Gálvez A; Abriouel H; López RL; Ben Omar N
    Int J Food Microbiol; 2007 Nov; 120(1-2):51-70. PubMed ID: 17614151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.